A Study of JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid Arthritis
Clinical trial NCT03161457 · TERMINATED
Trial details
- NCT number
- NCT03161457
- Sponsor
- JHL Biotech, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-27
- Primary completion
- 2019-04-16
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.